1. 1-24 of 655 1 2 3 4 ... 26 27 28 »
    1. Ortho Clinical Diagnostics Names Evelyn Dilsaver to Board of Directors

      Ortho Clinical Diagnostics Names Evelyn Dilsaver to Board of Directors

      RARITAN, N.J., Feb. 23, 2021 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world’s largest pure-play in vitro diagnostics (IVD) companies dedicated to transforming patient care, today announced that Evelyn Dilsaver, former CEO of Charles Schwab Investment Management, has been appointed as a member of its board of directors...

      Read Full Article
    2. ContraFect Announces Appointment of Dr. Jane F. Barlow to Board of Directors

      ContraFect Announces Appointment of Dr. Jane F. Barlow to Board of Directors

      YONKERS, N.Y., Feb. 11, 2021 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs) as new medical modalities for the treatment of life-threatening, antibiotic-resistant infections, today announced the appointment of Jane F. Barlow, MD, MPH, MBA to the Company’s board of directors...

      Read Full Article
    3. BlueLinx Announces Appointment of Carol B. Yancey to Board of Directors

      BlueLinx Announces Appointment of Carol B. Yancey to Board of Directors

      MARIETTA, Ga., Feb. 11, 2021 (GLOBE NEWSWIRE) -- BlueLinx Holdings Inc. (NYSE:BXC), a leading distributor of building and industrial products in the United States, today announced that Carol B. Yancey, the Executive Vice President and Chief Financial Officer of Genuine Parts Co. (“GPC”), a company listed on the New York Stock Exchange, has been appointed to BlueLinx’s Board of Directors...

      Read Full Article
    4. Equillium Announces the Appointment of Katherine Xu to the Board of Directors

      Equillium Announces the Appointment of Katherine Xu to the Board of Directors

      LA JOLLA, Calif., Feb. 09, 2021 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ) a clinical-stage biotechnology company developing itolizumab to treat severe autoimmune and inflammatory disorders, today announced that Y. Katherine Xu, Ph.D., partner at Decheng Capital, has been appointed to Equillium’s board of directors...

      Read Full Article
    5. Ziopharm Oncology Announces Election of Robert Postma to its Board of Directors

      Ziopharm Oncology Announces Election of Robert Postma to its Board of Directors

      (GLOBE NEWSWIRE) -- Ziopharm Oncology, Inc. (“Ziopharm” or “the Company”) (Nasdaq:ZIOP) today announced the election of Robert Postma to its Board of Directors (the “Board”), effective immediately. Mr. Postma is the Founder of WaterMill Asset Management, a sizeable and long-term shareholder of Ziopharm...

      Read Full Article
    1-24 of 655 1 2 3 4 ... 26 27 28 »
  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content